Zartan FC tablets
PDF Leaflet Revision Date: 30 August 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension and renal protection in type 2 diabetic patients.
Dosage (summary)
50 mg once daily, may increase to 100 mg.
Onset of Action / Duration
Onset: 3-6 weeks, Duration: Not specified
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy; safety in breastfeeding not established.
Key Drug Interactions
- Fluoroquinolones
- NSAIDs
- Potassium-sparing diuretics
- Lithium
Contraindications
- Hypersensitivity to losartan
- Severe renal impairment
- Bilateral renal artery stenosis
- Pregnancy
- Concomitant use with renin inhibitors
Common side effects
- Upper respiratory tract infections
- Headache
- Dizziness
- Cough
- Hyperkalaemia
Counselling Points
- Monitor blood pressure regularly
- Avoid potassium supplements
- Report any signs of angioedema
Serious warnings
- Risk of hypotension in volume-depleted patients
- Dual blockade of RAAS may increase adverse effects
Important Disclaimer
The Zartan FC tablets professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
